Whole-genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation
- PMID: 31621921
- DOI: 10.1002/path.5359
Whole-genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation
Abstract
The genetics underlying thyroid cancer dedifferentiation is only partly understood and has not yet been characterised using comprehensive pan-genomic analyses. We investigated a unique case with synchronous follicular thyroid carcinoma (FTC), poorly differentiated thyroid carcinoma (PDTC), and anaplastic thyroid carcinoma (ATC), as well as regional lymph node metastases from the PDTC and ATC from a single patient using whole-genome sequencing (WGS). The FTC displayed mutations in CALR, RB1, and MSH2, and the PDTC exhibited mutations in TP53, DROSHA, APC, TERT, and additional DNA repair genes - associated with an immense increase in sub-clonal somatic mutations. All components displayed an overrepresentation of C>T transitions with associated microsatellite instability (MSI) in the PDTC and ATC, with borderline MSI in the FTC. Clonality analyses pinpointed a shared ancestral clone enriched for mutations in TP53-associated regulation of DNA repair and identified important sub-clones for each tumour component already present in the corresponding preceding lesion. This genomic characterisation of the natural progression of thyroid cancer reveals several novel genes of interest for future studies. Moreover, the findings support the theory of a stepwise dedifferentiation process and suggest that defects in DNA repair could play an important role in the clonal evolution of thyroid cancer. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Keywords: DNA repair; clonality; dedifferentiation; thyroid carcinoma; whole-genome sequencing.
© 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Similar articles
-
Aberrant DNA repair as a potential contributor for the clonal evolution in subsets of anaplastic thyroid carcinomas arising through dedifferentiation: implications for future therapeutic algorithms?Cancer Drug Resist. 2020 Nov 3;3(4):992-1000. doi: 10.20517/cdr.2020.66. eCollection 2020. Cancer Drug Resist. 2020. PMID: 35582231 Free PMC article.
-
Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing.Histopathology. 2019 Dec;75(6):890-899. doi: 10.1111/his.13942. Epub 2019 Oct 13. Histopathology. 2019. PMID: 31230400
-
Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.Thyroid. 2019 Oct;29(10):1425-1437. doi: 10.1089/thy.2019.0284. Epub 2019 Aug 16. Thyroid. 2019. PMID: 31298630 Free PMC article.
-
Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma.Endocr Pathol. 2016 Sep;27(3):205-12. doi: 10.1007/s12022-016-9445-4. Endocr Pathol. 2016. PMID: 27372303 Review.
-
Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects.Thyroid. 2019 Mar;29(3):311-321. doi: 10.1089/thy.2018.0509. Thyroid. 2019. PMID: 30747050 Free PMC article. Review.
Cited by
-
Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.J Clin Endocrinol Metab. 2021 Oct 21;106(11):3265-3282. doi: 10.1210/clinem/dgab471. J Clin Endocrinol Metab. 2021. PMID: 34171097 Free PMC article.
-
Longitudinal Genomic Evolution of Conventional Papillary Thyroid Cancer With Brain Metastasis.Front Oncol. 2021 Jun 23;11:620924. doi: 10.3389/fonc.2021.620924. eCollection 2021. Front Oncol. 2021. PMID: 34249677 Free PMC article.
-
MicroRNA regulator gene mutations in thyroid follicular nodular disease and thyroid cancer: does it all come down to timing?Eur Thyroid J. 2024 Dec 19;13(6):e240298. doi: 10.1530/ETJ-24-0298. Print 2024 Dec 1. Eur Thyroid J. 2024. PMID: 39601261 Free PMC article. Review.
-
Spatial Transcriptomics in a Case of Follicular Thyroid Carcinoma Reveals Clone-Specific Dysregulation of Genes Regulating Extracellular Matrix in the Invading Front.Endocr Pathol. 2024 Jun;35(2):122-133. doi: 10.1007/s12022-024-09798-0. Epub 2024 Jan 27. Endocr Pathol. 2024. PMID: 38280140 Free PMC article.
-
Pan-Genomic Sequencing Reveals Actionable CDKN2A/2B Deletions and Kataegis in Anaplastic Thyroid Carcinoma.Cancers (Basel). 2021 Dec 17;13(24):6340. doi: 10.3390/cancers13246340. Cancers (Basel). 2021. PMID: 34944959 Free PMC article.
References
-
- Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol 2016; 12: 646-653.
-
- Carlberg M, Hedendahl L, Ahonen M, et al. Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data. BMC Cancer 2016; 16: 426.
-
- James BC, Aschebrook-Kilfoy B, Cipriani N, et al. The incidence and survival of rare cancers of the thyroid, parathyroid, adrenal, and pancreas. Ann Surg Oncol 2016; 23: 424-433.
-
- Lloyd RV, Osamura RY, Klöppel G, et al. (eds). WHO Classification of Tumours of Endocrine Organs (4th edn). International Agency for Research on Cancer: Lyon, 2017.
-
- Ibrahimpasic T, Ghossein R, Carlson DL, et al. Outcomes in patients with poorly differentiated thyroid carcinoma. J Clin Endocrinol Metab 2014; 99: 1245-1252.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous